Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-23-029715
Filing Date
2023-03-07
Accepted
2023-03-07 19:13:57
Documents
1
Period of Report
2023-01-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm238681-5_3a.html 3/A  
1 OWNERSHIP DOCUMENT tm238681-5_3a.xml 3/A 3007
  Complete submission text file 0001104659-23-029715.txt   4564
Mailing Address C/O PETER TSOFLIAS, BLANK ROME LLP ONE LOGAN SQUARE, FL 9 PHILADELPHA PA 19103
Business Address
LANGER DENNIS (Reporting) CIK: 0001274225 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-37846 | Film No.: 23714397

Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Issuer) CIK: 0001671502 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
SIC: 3841 Surgical & Medical Instruments & Apparatus